PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

Zi-Qi Zhou(Sun Yat-sen University), Jian‐Chuan Xia(Sun Yat-sen University)
Journal for ImmunoTherapy of Cancer
August 27, 2019
Cited by 57


Related Papers